KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -3.324 3 days ( 0 % )
Last Price $3.99 3.37 %
High/ Low $3.84 - $4.05 1.95%
Chg 7 Days -2.92 % $4.11 $3.99
Chg 30 Days -10.74 % $4.47 $3.99
Chg 12 mos 47.78 % $2.70 $3.99
Trend - 3 mos 22.97 % Width: 76.32 %
Trend - 12 mos 48.93 % Width: 152.63 %
Pred. range - 3 mos $3.54 - $6.25 -11.22 % - 56.54 %
Pred. range - 12 mos $3.07 - $7.75 -23.10 % - 94.27 %
Short MA avg 3 mos Buy Apr 22, 2024 - 5 days
Long MA avg 3 mos Sell Apr 23, 2024 - 4 days
Short/Long MA avg 3 mos Sell Apr 25, 2024 - 2 days
Short MA avg 12 mos Sell Apr 15, 2024 - 10 days
Long MA avg 12 mos Buy Feb 27, 2024 - 43 days
Short/Long MA avg 12 mos Buy Dec 05, 2023 - 99 days
Pivot Short Sell Apr 09, 2024 - 14 days
Bollinger Buy Sep 19, 2023 - 153 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About G1 Therapeutics Inc

G1 Therapeutics G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer... GTHX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT